Dow Up 0.19% Nasdaq Down 0.44%

Oncothyreon Inc (ONTY)

-NasdaqGS
2.10 Down 0.05(2.33%) 12:28PM EDT - Nasdaq Real Time Price
Prev Close:2.15
Open:2.13
Bid:2.10 x 1400
Ask:2.11 x 1800
1y Target Est:3.50
Beta:1.65
Next Earnings Date:N/A
Day's Range:2.10 - 2.15
52wk Range:1.67 - 4.08
Volume:321,496
Avg Vol (3m):781,361
Market Cap:148.70M
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ONTYDown 2.33%148.70M
GSKUp 0.66%114.34B
RHHBYDown 0.77%255.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:08-May-95

Analysts

Annual EPS Est (Dec-14) :-0.46
Quarterly EPS Est (Sep-14) :-0.11
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oncothyreon Inc, a clinical-stage biopharmaceutical company, develops therapeutic products for the treatment of cancer. Its product candidate includes Tecemotide, a vaccine for the treatment of non-small cell lung cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback